@misc{ostrowski_skin_barrier_2014, 
author={Ostrowski, A., Nordmeyer, D., Boreham, A., Brodwolf, R., Mundhenk, L., Fluhr, J.W., Lademann, J., Graf, C., Ruehl, E., Alexiev, U., Gruber, A.D.},
title={Skin barrier disruptions in tape stripped and allergic dermatitis models have no effect on dermal penetration and systemic distribution of AHAPS-functionalized silica nanoparticles},
year={2014},
howpublished = {journal article},
doi = {https://doi.org/10.1016/j.nano.2014.04.004},
abstract = {were studied. AHAPS-SiO2-NP (55 ± 6 nm diameter)were topically applied on intact, tape stripped or on inflamed skin of SKH1 mice with induced allergic contact dermatitis for one or five consecutive days, respectively. Penetration of AHAPS-SiO2-NP through the skin was not observed regardless of the kind of barrier disruption. However, only after subcutaneous injection, AHAPS-SiO2-NP were incorporated by macrophages and transported to the regional lymph node only. Adverse effects on cells or tissues were not observed. In conclusion, AHAPS-SiO2-NP seemto not cross the normal or perturbed mouse skin.},
note = {Online available at: \url{https://doi.org/10.1016/j.nano.2014.04.004} (DOI). Ostrowski, A.; Nordmeyer, D.; Boreham, A.; Brodwolf, R.; Mundhenk, L.; Fluhr, J.; Lademann, J.; Graf, C.; Ruehl, E.; Alexiev, U.; Gruber, A.: Skin barrier disruptions in tape stripped and allergic dermatitis models have no effect on dermal penetration and systemic distribution of AHAPS-functionalized silica nanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine. 2014. vol. 10, no. 7, 1571-1581. DOI: 10.1016/j.nano.2014.04.004}}